FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2320917772> ?p ?o ?g. }

• W2320917772 endingPage "1002" @default.
• W2320917772 startingPage "997" @default.
• W2320917772 abstract "Free AccessSurgeryMortality of Patients with Obstructive Sleep Apnea in Korea Ji-Eun Lee, M.D., Chul Hee Lee, M.D., Sun Joo Lee, M.D., Yoonjong Ryu, M.D., Woo-Hyun Lee, M.D., In Young Yoon, M.D., Chae-Seo Rhee, M.D., Jeong-Whun Kim, M.D. Ji-Eun Lee, M.D. Departments of Otorhinolaryngology Chosun University Hospital, Gwang-ju Search for more papers by this author , Chul Hee Lee, M.D. Seoul National University Bundang Hospital, Seongnam Seoul National University College of Medicine, Seoul Search for more papers by this author , Sun Joo Lee, M.D. Seoul National University College of Medicine, Seoul Search for more papers by this author , Yoonjong Ryu, M.D. Seoul National University College of Medicine, Seoul Search for more papers by this author , Woo-Hyun Lee, M.D. Seoul National University Bundang Hospital, Seongnam Seoul National University College of Medicine, Seoul Search for more papers by this author , In Young Yoon, M.D. Seoul National University College of Medicine, Seoul Department of Psychiatry, Seoul National University Bundang Hospital, Seongnam, Korea Search for more papers by this author , Chae-Seo Rhee, M.D. Seoul National University Bundang Hospital, Seongnam Seoul National University College of Medicine, Seoul Search for more papers by this author , Jeong-Whun Kim, M.D. Address correspondence to: Jeong-Whun Kim, M.D., Ph.D., Associate Professor, Department of Otorhinolaryngology, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 300 Goomi-dong, Bundang-gu, Seongnam, Gyeonggi-do, 464-707, South Korea+82-10-3079-7405031-787-7409 E-mail Address: [email protected] E-mail Address: [email protected] E-mail Address: [email protected] Seoul National University Bundang Hospital, Seongnam Seoul National University College of Medicine, Seoul Search for more papers by this author Published Online:October 15, 2013https://doi.org/10.5664/jcsm.3068Cited by:24SectionsAbstractPDF ShareShare onFacebookTwitterLinkedInRedditEmail ToolsAdd to favoritesDownload CitationsTrack Citations AboutABSTRACTBackground:Obstructive sleep apnea (OSA) is associated with diverse health risks, including death. However, the role of OSA as a risk factor for death has never been studied in Asians. This study is aimed at evaluating the influence of OSA on the mortality in Korean sleep clinic population.Methods:A total of 2,240 patients who underwent in-laboratory full-night polysomnography due to snoring or sleep apnea were included. The patients were categorized based on apnea-hypopnea index (AHI)/hour. Death records were provided from the Statistics Korea. A Cox-proportional hazard regression model and Kaplan-Meier survival curve were used for analysis and demonstration of the all-cause mortality and cardiovascular mortality.Results:The all-cause mortality risk adjusted for age, sex, body mass index, diabetes, hypertension, cardiovascular diseases, and previous history of stroke was significantly associated with the increased severity of OSA. The adjusted hazard ratio (HR) for all-cause mortality in the severe OSA group (AHI ≥ 30) vs. reference group (5 < AHI) was 2.47 (95% confidence interval [CI], 1.09-5.57) and the adjusted HR for cardiovascular mortality was 4.66 (CI 1.03-21.08). After adjusting for whether the patients were treated or untreated, the HR for all-cause and cardiovascular mortality in the severe OSA group vs. reference group were 2.14 (p = 0.079) and 4.19 (p = 0.076), respectively.Conclusions:The present study showed that the increased mortality was also associated with the increased severity of OSA in Koreans as shown in the studies performed in the Western countries.Citation:Lee JE; Lee CH; Lee SJ; Ryu Y; Lee WH; Yoon IY; Rhee CS; Kim JW. Mortality of patients with obstructive sleep apnea in Korea. J Clin Sleep Med 2013;9(10):997-1002.INTRODUCTIONObstructive sleep apnea (OSA) is a chronic condition characterized by frequent episodes of upper airway collapse during sleep. To date, epidemiologic studies have estimated that the prevalence of adults with apnea-hypopnea index (AHI) ≥ 5 is 17% to 26%.1–4 A population-based cohort study performed in the U.S. showed that the prevalence of mild (5 ≤ AHI < 15), moderate (15 ≤ AHI < 30), and severe OSA (AHI ≥ 30) in middle-aged adults was around 14%, 5%, and 4%, respectively. After the high prevalence of OSA was uncovered in adults, more attention was turned to its clinical significance in health2,5,6; there have been population-based and longitudinal studies to show its natural history and adverse health effects.2–5,7–9 OSA has been shown to be an important risk factor for many clinically important conditions, such as cardiovascular diseases, cerebrovascular diseases, metabolic syndrome, and even death.10–14 Moreover, if left untreated, it may lead to excessive daytime sleepiness, impaired congnitive function, depression, impaired work performance contributing to motor vehicle crashes and job-related accidents, and decrements in health-related quality of life.15While most of the epidemiologic studies have been performed in Western countries, there have been just a few epidemiologic studies in Asians. Although there was no significant difference between Asians and Caucasians in regard to prevalence, ethnicity might be a factor affecting comorbidities of OSA because there are differences, such as craniofacial morphology and body mass index (BMI).5,16,17 Furthermore, though the significance of OSA as an important risk factor for several diseases is widely accepted, the evidence supporting the association between OSA and mortality is not enough, even in the studies of Western countries.18–22 In the present study, we conducted an observational cohort study to evaluate mortality in the Korean sleep clinic population.BRIEF SUMMARYCurrent Knowledge/Study Rationale: There is a need to identify the relationship between OSA and mortality in Asians. Evidence supporting the influence of severe OSA on increased death risk is not sufficient, even in Western population-based studies. Furthermore, Asians are different from Caucasians in several aspects such as body fat composition and skeletal structure.Study Impact: In our Korean cohort, we identified that all-cause and cardiovascular mortality was significantly correlated with OSA severity. This study suggests that more attention should be paid to Asians with OSA and emphasizes the need for early detection of OSA and its efficient treatment.METHODSStudy SampleAn observational cohort in the Sleep Center of Seoul National University Bundang Hospital consisted of patients who visited the center due to snoring or witnessed sleep apnea from January 2003 through January 2009, underwent a full-night in-laboratory polysomnography (PSG), and were ≥ 40 years old. Subjects with total sleep time < 4 h were excluded from the present study. Data regarding demographic parameters, daytime sleepiness (Epworth Sleepiness Scale), and medical risk factors such as hypertension, diabetes, cardiovascular diseases, previous stroke history, and prescribed treatment were collected. Patients with AHI ≥ 5 underwent one of the following specific treatments: continuous positive airway pressure (CPAP); mandibular advancement device (MAD); upper airway surgery; or combination therapy of CPAP, MAD, or surgery. This study has been approved by the Seoul National University Bundang Hospital Institutional Review Board.Full-Night In-Laboratory PolysomnographyAll the subjects underwent a full-night in-laboratory PSG using an Embla N7000 recording system (Embla; Medcare, Reykjavik, Iceland) and standard electrodes and sensors with the supervision of an experienced technician at the sleep center as previously described.23–25 PSG included the following parameters: electroencephalography, electrooculography, submental electromyography, lower leg electromyography, electrocardiography, leg movement, chest and abdominal movement, nasal airflow, mouth airflow (thermistor), pulse oximetry, and body position. Based on the standard criteria, sleep stages were scored in 30-sec epochs. Apnea was defined as absence of the airflow ≥ 10 seconds. Hypopnea was defined as a recognizable reduction of the airflow with reduction of oxygen saturation ≥ 4% from the baseline or an arousal. Patients were categorized into 4 severity groups based on AHI: no OSA (reference, AHI < 5), mild OSA (5 ≤ AHI < 15), moderate OSA (15 ≤ AHI < 30), and severe OSA (AHI ≥ 30).Mortality StatusDeaths in the cohort having occurred up to December 31, 2011, were identified by matching each subject's Korean Identification Number and name with death records from the Statistics Korea, a national organization for statistics. The date of death and primary cause of death were collected from the national death statistics. The causes of death were categorized into 4 groups described in a previous report26: (1) cardiovascular diseases and stroke, including acute myocardial infarction, acute ischemic heart disease, sudden cardiac arrest, and cardiac dysrhythmias; (2) fatal events including accidents, injuries and falls; (3) cancer; (4) others, including pneumonia, gastrointestinal bleeding, end-stage renal disease, amyloidosis, and so forth.Statistical AnalysisKaplan-Meier survival analysis methods were used to compare survival rates according to the severity category with a log-rank test to assess statistical differences. A Cox proportional hazards regression analysis was used to estimate hazard ratios (HR) and 95% confidence interval (CI) adjusted for sex, age, BMI, and medical conditions such as diabetes, hypertension, cardiovascular diseases, previous history of stroke, and treatment for OSA. All significance tests were two-sided, and a value of p < 0.05 was considered statistically significant. SPSS version 18.0 (SPSS Inc., Chicago, IL) software was used.RESULTSBaseline CharacteristicsA total of 2,240 subjects (1,669 males and 571 females) were included in the present cohort. The average observation period was 61.4 months (range, 34.0-106.0 months). Of 2,240 subjects, 1,800 patients had AHI ≥ 5/h on PSG. The average age was 55 years (range 40-87 years). Baseline characteristics of the subjects are shown in Table 1. BMI increased as OSA severity increased. The prevalence of hypertension and diabetes mellitus was significantly higher in patients with OSA than in those without OSA (p < 0.001). The initial status of subjects in terms of cardiovascular diseases was not significantly different according to the severity of OSA (p = 0.780).Table 1 General characteristics of the patients with OSA and controlsTable 1 General characteristics of the patients with OSA and controlsAmong 1,800 patients with OSA, 735 patients were treated with CPAP (n = 227), MAD (n = 242), surgery (n = 203), or combined treatment (n = 63). The other 1,065 patients were not specifically treated because they were lost to follow-up, refused such treatments, wanted to reduce body weight, and/or to try to sleep in the lateral decubitus position.Mortality According to the Severity of OSAA total of 69 deaths (3.08%) were identified. The median age at death was 66.8 years (range, 42-86 years). All-cause mortality and cause-specific deaths are shown in Table 2. The mortality rate was 1.81%, 2.18%, 3.54%, and 4.20% in no OSA, mild, moderate, and severe OSA groups, respectively. Cardiovascular diseases or stroke accounted for 37.7% (26/69) of all deaths. Death from cardiovascular disease or stroke accounted for 25.0% (2/8), 16.7% (2/12), 42.1% (8/19), and 46.7.0% (14/30) of deaths in no OSA, mild, moderate, and severe OSA groups, respectively.Table 2 Cause-specific mortalityTable 2 Cause-specific mortalitySurvival Rate and Hazard RatioThere was no significant difference between males and females in the overall survival (p = 0.725). The increased OSA severity was likely to be associated with a reduction in survival probabilities (p = 0.054; Figure 1), and the difference was significant when patients with AHI < 30 were compared to those with AHI ≥ 30 (p = 0.030; Figure 2).Figure 1: Kaplan-Meier survival curves for all-cause deathsWhen the patients were classified into 4 groups—none (AHI < 5), mild (5 ≤ AHI < 15), moderate (15 ≤ AHI < 30), and severe (AHI ≥ 30)—the increased OSA severity was likely to be associated with a reduction in survival (p = 0.054). AHI, apnea-hypopnea index; OSA, obstructive sleep apnea.Download FigureFigure 2: Kaplan-Meier survival curves for all-cause deathsWhen the patients were classified into 2 groups, there was a significant difference in survival between the patients with AHI < 30 and those with AHI ≥ 30 (p = 0.030). AHI, apnea-hypopnea index; OSA, obstructive sleep apnea.Download FigureAfter adjustment for age, sex, and BMI, the trend analysis revealed that OSA retained a statistically significant association with death in a stepwise increasing pattern (Table 3). The adjusted HR for all-cause mortality in the severe OSA group vs. reference group was 2.47 (95% CI 1.01-5.55; p = 0.028). After adjustment for age, sex, BMI, hypertension, diabetes, cardiovascular diseases, and previous history of stroke, the adjusted HR for all-cause mortality in the severe OSA group vs. reference group was 2.47 (95% CI 1.09-5.57; p = 0.030). After adjusting for whether the patients were treated or untreated, the HR for all-cause mortality in the severe OSA group vs. reference group was 2.14 (95% CI 0.91-5.03; p = 0.079).Table 3 Hazard ratios for all-cause mortalityTable 3 Hazard ratios for all-cause mortalityThe cardiovascular mortality adjusted for age, sex, BMI, hypertension, diabetes, cardiovascular diseases, and previous history of stroke was significantly elevated in the severe OSA group vs. reference group (HR 4.66; 95% CI 1.03-21.08; p = 0.046; Table 4). After prescription of treatment was added as a covariate to the hazard model, the adjusted HR for cardiovascular mortality was 4.19 (95% CI 0.85-20.4; p = 0.076) in severe OSA group vs. reference group.Table 4 Hazard ratios for cardiovascular mortalityTable 4 Hazard ratios for cardiovascular mortalityThe HR for all-cause death in OSA patients who did not have cardiovascular diseases other than hypertension at enrollment was analyzed. A total of 156 patients had cardiovascular disease at baseline. The HR for mortality adjusted by age, sex, and BMI was 2.17 (95% CI 0.95-4.96; p = 0.066) in the severe OSA group vs. reference group (Table 5).Table 5 Hazard ratios for all-cause death in subjects without cardiovascular diseases or history of stroke at baselineTable 5 Hazard ratios for all-cause death in subjects without cardiovascular diseases or history of stroke at baselineDISCUSSIONThis is an observational cohort study conducted in a large Korean sleep clinic population to investigate the influence of OSA on mortality. To our best knowledge, the present study showed a significant association between OSA and mortality in Asians for the first time. The present study demonstrated that OSA may be a significant risk factor for death in Asians as previously shown in the Western population.22,26 Asians are different from Caucasians in some aspects important for OSA. Firstly, Asians are generally known to have a higher percentage of body fat than the Western population at the same BMI level.27 Previous comparative studies of Asian and Caucasian male patients with OSA demonstrated that Asians were less obese despite the presence of severe OSA,28,29 even when matched for risk factors such as age, gender, and BMI. The higher central fat distribution was found at a lower level of BMI in Asians than in Caucasians.30,31 Secondly, Asians have smaller mandibles; therefore, the upper airway may be more collapsible and have propensity for more severe OSA. Cephalometric analysis revealed that the Asians have maxillomandibular protrusion, narrower cranial base angle, larger posterior airway space, and more superiorly positioned hyoid bone compared with Caucasians.29,31 The narrower cranial base in the Asian population may have an important implication in the pathogenesis of OSA because it affects particularly the airway in the nasopharygneal and retropalatal regions. Thus, epidemiologic data of OSA acquired from the Western population cannot be directly applied to Asians, and independent investigations for Asians are mandatory.16,28,30,32Our study indicated that the all-cause mortality risk was 2.47 times higher in subjects with OSA with AHI ≥ 30 compared to those with AHI < 5, independent of age, sex, BMI, and other chronic diseases. After excluding patients diagnosed as having cardiovascular disease at the time of enrollment, severe OSA tended to be associated with increased all-cause mortality compared to the reference group. In a large population-based study performed in the U.S., the adjusted HR for all-cause mortality in subjects with AHI ≥ 30 in comparison to those with AHI < 5 was 3.0, and it increased to 3.8 when the persons under treatment with continuous positive airway pressure were excluded.26 An observational cohort study of a large population of the U.S. also showed a significant association of OSA with stroke or death.22 In the above study, both OSA patients and controls were recruited from the population referred to sleep centers. In another observational cohort study conducted in Spain, patients with OSA enrolled from a sleep clinic were compared to the general population. It was shown that mortality was significantly higher in subjects with untreated severe OSA than in healthy controls.33,34Our study also investigated the influences of cardiovascular disease on the association between OSA and cardiovascular mortality by including or excluding the initial status of cardiovascular diseases at baseline. Cardiovascular mortality was significantly higher in the group with severe OSA compared to the reference group. When the initial presence of cardiovascular diseases was adjusted, the severe OSA group tended to be associated with increased all-cause mortality compared to the reference group. This finding suggests that severe OSA may be an independent risk factor increasing cardiovascular mortality in Asians. In addition, an analysis in subjects without cardiovascular diseases or stroke at baseline showed that OSA with AHI ≥ 30 was likely to be a risk factor for death in the above condition.We also investigated the effect of OSA therapy on mortality irrespective of therapeutic modalities as in the previous studies,11,19,35–38 by evaluating mortality according to whether the patients were treated. Although the risk of death was significantly higher in the severe OSA group, there was no significant difference in mortality between the severe OSA group and reference group after adjusting for the treatment factor. These may indicate the potential beneficial effects of treatment for OSA on mortality associated with severe OSA. This finding is consistent with the results of several other studies, revealing a greater mortality in patients with untreated OSA.21,26,39Our study has some limitations. Firstly, as our study is not population based, there could be a selection bias resulting in overestimation of the mortality. Secondly, since our public health insurance program does not reimburse the cost of PSG, it is likely that the cohort consisted of patients with somewhat greater income and access to medical service; thus our finding might underestimate the real mortality risk of OSA. Thirdly, the average follow-up period of 61.4 months may not be sufficient to determine the association between OSA severity and mortality. This could lead to underestimation of the risk. Fourthly, we could not exactly assess the effects of treatment on the risk of death according to the therapeutic modality because the adherence and compliance for the treatment were not fully evaluated for all the patients.CONCLUSIONThe present study has a clinical implication that increased mortality, shown in studies in Western countries, is also associated with increased severity of OSA in Asians. In particular, severe OSA (AHI ≥ 30) was an independent risk factor for death. These findings emphasize the need for early detection of OSA and its efficient treatment and follow-up. Since this study has a limitation of an observational cohort study, a longitudinal randomized controlled study is necessary to show the association between OSA and mortality in Asians in the future.DISCLOSURE STATEMENTThis was not an industry supported study. The authors have indicated no financial conflicts of interest.REFERENCES1 Guilleminault C, Tilkian A, Dement WCThe sleep apnea syndromes. Annu Rev Med; 1976;27:465-84, 180875. CrossrefGoogle Scholar2 Young T, Palta M, Dempsey J, Skatrud J, Weber S, Badr SThe occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med; 1993;328:1230-5, 8464434. CrossrefGoogle Scholar3 Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales AEffects of age on sleep apnea in men: I. Prevalence and severity. Am J Respir Crit Care Med; 1998;157:144-8, 9445292. CrossrefGoogle Scholar4 Duran J, Esnaola S, Rubio R, Iztueta AObstructive sleep apnea-hypopnea and related clinical features in a population-based sample of subjects aged 30 to 70 yr. Am J Respir Crit Care Med; 2001;163:685-9, 11254524. CrossrefGoogle Scholar5 Kripke DF, Ancoli-Israel S, Klauber MR, Wingard DL, Mason WJ, Mullaney DJPrevalence of sleep-disordered breathing in ages 40-64 years: a population-based survey. Sleep; 1997;20:65-76, 9130337. CrossrefGoogle Scholar6 Gislason T, Almqvist M, Eriksson G, Taube A, Boman GPrevalence of sleep apnea syndrome among Swedish men--an epidemiological study. J Clin Epidemiol; 1988;41:571-6, 3385458. CrossrefGoogle Scholar7 Quan SF, Howard BV, Iber Cet al.The Sleep Heart Health Study: design, rationale, and methods. Sleep; 1997;20:1077-85, 9493915. Google Scholar8 Bixler EO, Vgontzas AN, Lin HMet al.Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med; 2001;163:608-13, 11254512. CrossrefGoogle Scholar9 Redline S, Tosteson T, Tishler PV, Carskadon MA, Millman RPStudies in the genetics of obstructive sleep apnea. Familial aggregation of symptoms associated with sleep-related breathing disturbances. Am Rev Respir Dis; 1992;145:440-4, 1736754. CrossrefGoogle Scholar10 Lindberg E, Janson C, Svardsudd K, Gislason T, Hetta J, Boman GIncreased mortality among sleepy snorers: a prospective population based study. Thorax; 1998;53:631-7, 9828847. CrossrefGoogle Scholar11 Ancoli-Israel S, Kripke DF, Klauber MRet al.Morbidity, mortality and sleep-disordered breathing in community dwelling elderly. Sleep; 1996;19:277-82, 8776783. CrossrefGoogle Scholar12 Mooe T, Rabben T, Wiklund U, Franklin KA, Eriksson PSleep-disordered breathing in men with coronary artery disease. Chest; 1996;109:659-63, 8617073. CrossrefGoogle Scholar13 Koskenvuo M, Kaprio J, Telakivi T, Partinen M, Heikkila K, Sarna SSnoring as a risk factor for ischaemic heart disease and stroke in men. BMJ (Clin Res Ed); 1987;294:16-9. CrossrefGoogle Scholar14 Shahar E, Whitney CW, Redline Set al.Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med; 2001;163:19-25, 11208620. CrossrefGoogle Scholar15 Leger DThe cost of sleep-related accidents: a report for the National Commission on Sleep Disorders Research. Sleep; 1994;17:84-93, 7677805. CrossrefGoogle Scholar16 Ip MS, Lam B, Lauder IJet al.A community study of sleep-disordered breathing in middle-aged Chinese men in Hong Kong. Chest; 2001;119:62-9, 11157585. CrossrefGoogle Scholar17 Kim J, In K, You Set al.Prevalence of sleep-disordered breathing in middle-aged Korean men and women. Am J Respir Crit Care Med; 2004;170:1108-13, 15347562. CrossrefGoogle Scholar18 He J, Kryger MH, Zorick FJ, Conway W, Roth TMortality and apnea index in obstructive sleep apnea: experience in 385 male patients. Chest; 1988;94:9-14, 3289839. CrossrefGoogle Scholar19 Lavie P, Lavie L, Herer PAll-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J; 2005;25:514-20, 15738297. CrossrefGoogle Scholar20 Campos-Rodriguez F, Pena-Grinan N, Reyes-Nunez Net al.Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest; 2005;128:624-33, 16100147. CrossrefGoogle Scholar21 Wang H, Parker JD, Newton GEet al.Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol; 2007;49:1625-31, 17433953. CrossrefGoogle Scholar22 Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin VObstructive sleep apnea as a risk factor for stroke and death. N Engl J Med; 2005;353:2034-41, 16282178. CrossrefGoogle Scholar23 Lee CH, Kim JW, Lee HJet al.Determinants of treatment outcome after use of the mandibular advancement device in patients with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg; 2010;136:677-81, 20644062. CrossrefGoogle Scholar24 Lee CH, Kim JW, Lee HJet al.An investigation of upper airway changes associated with mandibular advancement device using sleep videofluoroscopy in patients with obstructive sleep apnea. Arch Otolaryngol Head Neck Surg; 2009;135:910-4, 19770424. CrossrefGoogle Scholar25 Lee CH, Mo JH, Seo BS, Kim DY, Yoon IY, Kim JWMouth opening during sleep may be a critical predictor of surgical outcome after uvulopalatopharyngoplasty for obstructive sleep apnea. J Clin Sleep Med; 2010;6:157-62, 20411693. LinkGoogle Scholar26 Young T, Finn L, Peppard PEet al.Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep; 2008;31:1071-8, 18714778. Google Scholar27 Jee SH, Sull JW, Park Jet al.Body-mass index and mortality in Korean men and women. N Engl J Med; 2006;355:779-87, 16926276. CrossrefGoogle Scholar28 Ong KC, Clerk AAComparison of the severity of sleep-disordered breathing in Asian and Caucasian patients seen at a sleep disorders center. Respir Med; 1998;92:843-8, 9850368. CrossrefGoogle Scholar29 Li KK, Powell NB, Kushida C, Riley RW, Adornato B, Guilleminault CA comparison of Asian and white patients with obstructive sleep apnea syndrome. Laryngoscope; 1999;109:1937-40, 10591350. CrossrefGoogle Scholar30 Li KK, Kushida C, Powell NB, Riley RW, Guilleminault CObstructive sleep apnea syndrome: a comparison between Far-East Asian and white men. Laryngoscope; 2000;110:1689-93, 11037826. CrossrefGoogle Scholar31 Villaneuva AT, Buchanan PR, Yee BJ, Grunstein RREthnicity and obstructive sleep apnoea. Sleep Med Rev; 2005;9:419-36, 16183307. CrossrefGoogle Scholar32 Sakakibara H, Tong M, Matsushita K, Hirata M, Konishi Y, Suetsugu SCephalometric abnormalities in non-obese and obese patients with obstructive sleep apnoea. Eur Respir J; 1999;13:403-10, 10065689. CrossrefGoogle Scholar33 Marti S, Sampol G, Munoz Xet al.Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J; 2002;20:1511-8, 12503712. CrossrefGoogle Scholar34 Marin JM, Carrizo SJ, Vicente E, Agusti AGLong-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet; 2005;365:1046-53, 15781100. CrossrefGoogle Scholar35 Bliwise DL, Bliwise NG, Partinen M, Pursley AM, Dement WCSleep apnea and mortality in an aged cohort. Am J Public Health; 1988;78:544-7, 3354738. CrossrefGoogle Scholar36 Mant A, King M, Saunders NA, Pond CD, Goode E, Hewitt HFour-year follow-up of mortality and sleep-related respiratory disturbance in non-demented seniors. Sleep; 1995;18:433-8, 7481414. CrossrefGoogle Scholar37 Marshall NS, Wong KK, Liu PY, Cullen SR, Knuiman MW, Grunstein RRSleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep; 2008;31:1079-85, 18714779. Google Scholar38 Punjabi NM, Caffo BS, Goodwin JLet al.Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med; 2009;6:e1000132, 19688045. CrossrefGoogle Scholar39 Cassar A, Morgenthaler TI, Lennon RJet al.Treatment of obstructive sleep apnea is associated with decreased cardiac death after percutaneous coronary intervention. J Am Coll Cardiol; 2007;49:1625-31, 17433953. Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep ApneaGervès-Pinquié C, Bailly S, Goupil F, Pigeanne T, Launois S, Leclair-Visonneau L, Masson P, Bizieux-Thaminy A, Blanchard M, Sabil A, Jaffuel D, Racineux J, Trzepizur W and Gagnadoux F American Journal of Respiratory and Critical Care Medicine, 10.1164/rccm.202202-0366OC, Vol. 206, No. 11, (1393-1404), Online publication date: 1-Dec-2022. Whole-genome metagenomic analysis of the oral microbiota in patients with obstructive sleep apneaGao Y, Wang H, HU Y, Li J, Xu W, Zhao L, Su X, Han J, Li T, Fang X and Liu L Sleep and Breathing, 10.1007/s11325-022-02732-w Prediction of Oxygen Desaturation by Using Sound Data From a Noncontact Device: A Proof‐of‐Concept StudyKim J, Shin J, Lee K, Won T, Rhee C and Cho S The Laryngoscope, 10.1002/lary.29971, Vol. 132, No. 4, (901-905), Online publication date: 1-Apr-2022. Nonalcoholic fatty liver disease is associated with the development of obstructive sleep apneaChung G, Cho E, Yoo J, Chang Y, Cho Y, Park S, Shin D, Han K and Yu S Scientific Reports, 10.1038/s41598-021-92703-0, Vol. 11, No. 1 Sudden death in individuals with obstructive sleep apnoea: a systematic review and meta-analysisHeilbrunn E, Ssentongo P, Chinchilli V, Oh J and Ssentongo A BMJ Open Respiratory Research, 10.1136/bmjresp-2020-000656, Vol. 8, No. 1, (e000656), Online publication date: 1-Jun-2021. Sleep duration and mortality in Korean adults: a population-based prospective cohort studyKwon S, Lee H, Lee J, Shin M, Choi S and Oh H BMC Public Health, 10.1186/s12889-020-09720-3, Vol. 20, No. 1, Online publication date: 1-Dec-2020. Impact of short‐acting vs. standard anaesthetic agents on obstructive sleep apnoea: a randomised, controlled, triple‐blind trialAlbrecht E, Bayon V, Hirotsu C and Heinzer R Anaesthesia, 10.1111/anae.15236 Polysomnographic phenotyping of obstructive sleep apnea and its implications in mortality in KoreaKim J, Won T, Rhee C, Park Y, Yoon I and Cho S Scientific Reports, 10.1038/s41598-020-70039-5, Vol. 10, No. 1 Prevalence of obstructive sleep apnea risk and associated factors among patients with type 2 diabetes mellitus on follow up at Jimma Medical Center, Southwest EthiopiaAbdissa D Journal of Clinical & Translational Endocrinology, 10.1016/j.jcte.2020.100234, , (100234), Online publication date: 1-Aug-2020. Mortality and morbidity in obstructive sleep apnoea–hypopnoea syndrome: results from a 30-year prospective cohort studyDodds S, Williams L, Roguski A, Vennelle M, Douglas N, Kotoulas S and Riha R ERJ Open Research, 10.1183/23120541.00057-2020, Vol. 6, No. 3, (00057-2020), Online publication date: 1-Jul-2020. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of strokeBassetti C, Randerath W, Vignatelli L, Ferini‐Strambi L, Brill A, Bonsignore M, Grote L, Jennum P, Leys D, Minnerup J, Nobili L, Tonia T, Morgan R, Kerry J, Riha R, McNicholas W and Papavasileiou V European Journal of Neurology, 10.1111/ene.14201 Effect of ventilation therapy on mortality rate among obesity hypoventilation syndrome and obstructive sleep apnoea patientsKreivi H, Itäluoma T and Bachour A ERJ Open Research, 10.1183/23120541.00101-2019, Vol. 6, No. 2, (00101-2019), Online publication date: 1-Apr-2020. EAN/ERS/ESO/ESRS statement on the impact of sleep disorders on risk and outcome of strokeBassetti C, Randerath W, Vignatelli L, Ferini-Strambi L, Brill A, Bonsignore M, Grote L, Jennum P, Leys D, Minnerup J, Nobili L, Tonia T, Morgan R, Kerry J, Riha R, McNicholas W and Papavasileiou V European Respiratory Journal, 10.1183/13993003.01104-2019, Vol. 55, No. 4, (1901104), Online publication date: 1-Apr-2020. Association of upper airway surgery and improved cardiovascular biomarkers and risk in OSAQian Y, Zou J, Xu H, Zhu H, Meng L, Liu S, Yi H, Guan J and Yin S The Laryngoscope, 10.1002/lary.28012, Vol. 130, No. 3, (818-824), Online publication date: 1-Mar-2020. Apnea–Hypopnea Event Duration Predicts Mortality in Men and Women in the Sleep Heart Health StudyButler M, Emch J, Rueschman M, Sands S, Shea S, Wellman A and Redline S American Journal of Respiratory and Critical Care Medicine, 10.1164/rccm.201804-0758OC, Vol. 199, No. 7, (903-912), Online publication date: 1-Apr-2019. Implementation of an obstructive sleep apnea screening tool with hypertensive patients in the primary care clinicShowalter L and OʼKeefe C Journal of the American Association of Nurse Practitioners, 10.1097/JXX.0000000000000124, Vol. 31, No. 3, (184-188), Online publication date: 1-Mar-2019. Correlation of Body Mass Index Standard of Obesity with Severe Obstructive Sleep Apnea in Korean Male PatientsAhn K, Oh S, Cho J, Joo J, Kye S and Kim J Journal of Clinical Otolaryngology Head and Neck Surgery, 10.35420/jcohns.2018.29.1.53, Vol. 29, No. 1, (53-56), Online publication date: 1-Jun-2018. Sex and age differences in the associations between sleep behaviors and all-cause mortality in older adults: results from the National Health and Nutrition Examination SurveysBeydoun H, Beydoun M, Chen X, Chang J, Gamaldo A, Eid S and Zonderman A Sleep Medicine, 10.1016/j.sleep.2017.05.006, Vol. 36, , (141-151), Online publication date: 1-Aug-2017. Meta-analysis of all-cause and cardiovascular mortality in obstructive sleep apnea with or without continuous positive airway pressure treatmentFu Y, Xia Y, Yi H, Xu H, Guan J and Yin S Sleep and Breathing, 10.1007/s11325-016-1393-1, Vol. 21, No. 1, (181-189), Online publication date: 1-Mar-2017. Coagulation markers in patients with obstructive sleep apnea syndrome and effects of continuous positive airway pressureBugaev T, Elfimova E, Ageeva N, Dobrovolskiy A and Litvin A Systemic Hypertension, 10.26442/SG29157, Vol. 13, No. 4, (41-46) Sleep Disturbances among Older Adults in the United States, 2002–2012: Nationwide Inpatient Rates, Predictors, and OutcomesGamaldo A, Beydoun M, Beydoun H, Liang H, Salas R, Zonderman A, Gamaldo C and Eid S Frontiers in Aging Neuroscience, 10.3389/fnagi.2016.00266, Vol. 8, An Official American Thoracic Society Research Statement: Impact of Mild Obstructive Sleep Apnea in AdultsChowdhuri S, Quan S, Almeida F, Ayappa I, Batool-Anwar S, Budhiraja R, Cruse P, Drager L, Griss B, Marshall N, Patel S, Patil S, Knight S, Rowley J and Slyman A American Journal of Respiratory and Critical Care Medicine, 10.1164/rccm.201602-0361ST, Vol. 193, No. 9, (e37-e54), Online publication date: 1-May-2016. Obstructive sleep apnoea and risks of all-cause mortality: preliminary evidence from prospective cohort studiesPan L, Xie X, Liu D, Ren D and Guo Y Sleep and Breathing, 10.1007/s11325-015-1295-7, Vol. 20, No. 1, (345-353), Online publication date: 1-Mar-2016. Obstructive sleep apnea among hospitalized patients in Spain, analysis of hospital discharge data 2008–2012de Miguel-Díez J, Carrasco-Garrido P, Jiménez-García R, Puente-Maestu L, Hernández-Barrera V and López de Andrés A Sleep and Breathing, 10.1007/s11325-014-1104-8, Vol. 19, No. 3, (841-848), Online publication date: 1-Sep-2015. Volume 09 • Issue 10 • October 15, 2013ISSN (print): 1550-9389ISSN (online): 1550-9397Frequency: Monthly Metrics History Submitted for publicationJanuary 1, 2013Submitted in final revised formMay 1, 2013Accepted for publicationMay 1, 2013Published onlineOctober 15, 2013 Information© 2013 American Academy of Sleep MedicineKeywordsAsiansall-cause mortalityObstructive sleep apneacohortsleep disordered breathingcardiovascular mortalityPDF download" @default.
• W2320917772 created "2016-06-24" @default.
• W2320917772 creator A5014390131 @default.
• W2320917772 creator A5018869195 @default.
• W2320917772 creator A5023703170 @default.
• W2320917772 creator A5041184762 @default.
• W2320917772 creator A5048533649 @default.
• W2320917772 creator A5050118062 @default.
• W2320917772 creator A5066642482 @default.
• W2320917772 creator A5080982091 @default.
• W2320917772 date "2013-10-15" @default.
• W2320917772 modified "2023-09-28" @default.
• W2320917772 title "Mortality of Patients with Obstructive Sleep Apnea in Korea" @default.
• W2320917772 cites W160785014 @default.
• W2320917772 cites W1714259827 @default.
• W2320917772 cites W1745044191 @default.
• W2320917772 cites W182187739 @default.
• W2320917772 cites W193715454 @default.
• W2320917772 cites W1965055323 @default.
• W2320917772 cites W1970596096 @default.
• W2320917772 cites W1973085707 @default.
• W2320917772 cites W1979526825 @default.
• W2320917772 cites W1982292534 @default.
• W2320917772 cites W1988802440 @default.
• W2320917772 cites W2003915865 @default.
• W2320917772 cites W2011850120 @default.
• W2320917772 cites W2019250434 @default.
• W2320917772 cites W2031374244 @default.
• W2320917772 cites W2033816013 @default.
• W2320917772 cites W2034556696 @default.
• W2320917772 cites W2056032242 @default.
• W2320917772 cites W2065808972 @default.
• W2320917772 cites W2066596973 @default.
• W2320917772 cites W2068328326 @default.
• W2320917772 cites W2081159777 @default.
• W2320917772 cites W2085814883 @default.
• W2320917772 cites W2086261438 @default.
• W2320917772 cites W2098983190 @default.
• W2320917772 cites W2102403914 @default.
• W2320917772 cites W2103939721 @default.
• W2320917772 cites W2113283606 @default.
• W2320917772 cites W2113765726 @default.
• W2320917772 cites W2142403514 @default.
• W2320917772 cites W2144641374 @default.
• W2320917772 cites W2148345618 @default.
• W2320917772 cites W2150017574 @default.
• W2320917772 cites W2163889059 @default.
• W2320917772 cites W2172233351 @default.
• W2320917772 cites W2333343699 @default.
• W2320917772 cites W2418036837 @default.
• W2320917772 cites W2785563066 @default.
• W2320917772 cites W5967079 @default.
• W2320917772 doi "https://doi.org/10.5664/jcsm.3068" @default.
• W2320917772 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3778190" @default.
• W2320917772 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24127143" @default.
• W2320917772 hasPublicationYear "2013" @default.
• W2320917772 type Work @default.
• W2320917772 sameAs 2320917772 @default.
• W2320917772 citedByCount "33" @default.
• W2320917772 countsByYear W23209177722013 @default.
• W2320917772 countsByYear W23209177722015 @default.
• W2320917772 countsByYear W23209177722016 @default.
• W2320917772 countsByYear W23209177722017 @default.
• W2320917772 countsByYear W23209177722018 @default.
• W2320917772 countsByYear W23209177722019 @default.
• W2320917772 countsByYear W23209177722020 @default.
• W2320917772 countsByYear W23209177722021 @default.
• W2320917772 countsByYear W23209177722022 @default.
• W2320917772 crossrefType "journal-article" @default.
• W2320917772 hasAuthorship W2320917772A5014390131 @default.
• W2320917772 hasAuthorship W2320917772A5018869195 @default.
• W2320917772 hasAuthorship W2320917772A5023703170 @default.
• W2320917772 hasAuthorship W2320917772A5041184762 @default.
• W2320917772 hasAuthorship W2320917772A5048533649 @default.
• W2320917772 hasAuthorship W2320917772A5050118062 @default.
• W2320917772 hasAuthorship W2320917772A5066642482 @default.
• W2320917772 hasAuthorship W2320917772A5080982091 @default.
• W2320917772 hasBestOaLocation W23209177721 @default.
• W2320917772 hasConcept C111919701 @default.
• W2320917772 hasConcept C126322002 @default.
• W2320917772 hasConcept C164705383 @default.
• W2320917772 hasConcept C177713679 @default.
• W2320917772 hasConcept C187212893 @default.
• W2320917772 hasConcept C194828623 @default.
• W2320917772 hasConcept C2775841894 @default.
• W2320917772 hasConcept C2776006263 @default.
• W2320917772 hasConcept C2777935920 @default.
• W2320917772 hasConcept C2778205975 @default.
• W2320917772 hasConcept C2781326671 @default.
• W2320917772 hasConcept C2911073662 @default.
• W2320917772 hasConcept C41008148 @default.
• W2320917772 hasConcept C71924100 @default.
• W2320917772 hasConceptScore W2320917772C111919701 @default.
• W2320917772 hasConceptScore W2320917772C126322002 @default.
• W2320917772 hasConceptScore W2320917772C164705383 @default.
• W2320917772 hasConceptScore W2320917772C177713679 @default.
• W2320917772 hasConceptScore W2320917772C187212893 @default.
• W2320917772 hasConceptScore W2320917772C194828623 @default.

• next